In the patients with a clinical phenotype compatible with IPEX, approximately 50% were found to have mutations in FOXP3. These include missense, splice site, and deletion mutations [18]. This evidence concerns the gene FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.